Taysha Gene Therapies, Inc. reported financial results for fiscal year ended December 31, 2025.
“Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update”
Earnings Releases
Quarterly and annual results disclosed under 8-K Item 2.02.
FiscalNote Holdings, Inc. reported financial results for year ended December 31, 2025.
“On March 19, 2026, FiscalNote Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2025.”
FiscalNote Holdings, Inc. reported fourth quarter ended December 31, 2025 results: revenue $ 22.2, net income $ (22.9 ).
“Fourth Quarter 2025 Financial Highlights (2) (Unaudited) Three Months Ended December 31, ($ in millions) 2025 2024 % Change Total Revenues $ 22.2 $ 29.5 (25 ) % Subscription Revenue as % of Total Revenues 95 % 92 % 300 bps Gross Profit $ 17.7 $ 24.2 (27 ) % Gross Margin 80 % 82 % (200 ) bps Adjusted Gross Profit (1) $ 19.5 $ 25.7 (24 ) % Adjusted Gross Margin (1) 88 % 87 % 100 bps Net Loss $ (22.9 ) $ (13.4 ) 71 % Adjusted EBITDA (1) $ 2.5 $ 3.3 (25 ) % Adjusted EBITDA Margin (1) 11 % 11 % (200 ) bps Cash and Cash Equivalents $ 26.9 $ 35.3 bps - Basis Points Note: All amounts for the three months ended December 31, 2024 include contributions from: (i) TimeBase, divested on July 1, 2025; (ii) Oxford Analytica and Dragonfly Intelligence, both divested on March 31, 2025; and, (iii) Aicel, divested on October 31, 2024.”
Sky Harbour Group Corp reported financial results for the year ended December 31, 2025.
“On March 19, 2026, Sky Harbour Group Corporation (the “Company”) issued a press release (the “Press Release”) which announced its financial results for the year ended December 31, 2025.”
Aveanna Healthcare Holdings, Inc. reported three-month period ended January 3, 2026 results: revenue $662.5 million, net income $178.8 million, EPS $0.80 per diluted share. Guidance reaffirmed.
“Revenue was $662.5 million for the three-month period ended January 3, 2026, as compared to $519.9 million for the three-month period ended December 28, 2024, an increase of $142.6 million, or 27.4%. The overall increase in revenue was attributable to a $118.5 million increase in PDS segment revenue, a $14.9 million increase in HHH segment revenue, and a $9.2 million increase in MS segment revenue compared to the fourth quarter of 2024. Gross margin was $213.3 million, or 32.2% of revenue, for the three-month period ended January 3, 2026, as compared to $171.7 million, or 33.0% of revenue, for the three-month period ended December 28, 2024, an increase of $41.6 million, or 24.2%. Net income was $178.8 million for the three-month period ended January 3, 2026, as compared to net income of $29.2 million for the three-month period ended December 28, 2024. Net income per diluted share was $0.80 for the three-month period ended January 3, 2026, as compared to net income per diluted share of”
Planet Labs PBC reported its fourth fiscal quarter and full year ended January 31, 2026 results: revenue $86.8 million, net income ($152.5) million, EPS ($0.48).
“sustainable, profitable growth.” Fiscal Fourth Quarter and Full Year 2026 Financial and Key Metric Highlights: • Fourth quarter revenue increased 41% year-over-year to a record $86.8 million. • Full year revenue increased 26% year-over-year to a record $307.7 million. • Percent of recurring annual contract value (ACV) was 98% as of the end of fiscal year 2026. •”
Chicago Atlantic BDC, Inc. reported the fiscal year ended December 31, 2025 results: revenue $54.3 million, net income $33.1 million, EPS $1.45 per weighted average share.
“For the fiscal year ended December 31, 2025, total investment income was approximately $54.3 million. For the fiscal year ended December 31, 2025, the Company incurred net expenses of approximately $21.2 million, resulting in net investment income of approximately $33.1 million, or $1.45 per weighted average share, and a net increase in net assets from operations of approximately $33.3 million, or $1.46 per weighted average share.”
Chicago Atlantic BDC, Inc. reported the three months ended December 31, 2025 results: revenue $14.2 million, net income $8.3 million, EPS $0.36 per weighted average share.
“For the three months ended December 31, 2025, total investment income was approximately $14.2 million. For the three months ended December 31, 2025, the Company incurred net expenses of approximately $5.9 million, resulting in net investment income of approximately $8.3 million, or $0.36 per weighted average share, and a net increase in net assets from operations of approximately $8.2 million, or $0.36 per weighted average share.”
Intuitive Machines, Inc. updated its the full-year ended December 31, 2025 guidance (initiated).
“Intuitive Machines Reports Fourth Quarter and Full-Year 2025 Financial Results”
Intuitive Machines, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $44.8 million. Guidance initiated.
“Achieved $44.8 million of revenue in Q4 driven primarily by Commercial Lunar Payload Services (CLPS), Omnibus Multidiscipline Engineering Services III (OMES III), and Near Space Network Services (NSNS)”
ALUMIS INC. reported the year ended December 31, 2025 results: revenue license revenue of $17.4 million and collaboration revenue of $6.7 million, net income Net loss was $243.3 million.
“Revenue included license revenue of $17.4 million and collaboration revenue of $6.7 million for the year ended December 31, 2025, related to the collaboration and licensing agreement with Kaken Pharmaceutical Co., Ltd. ● Research and development expenses were $386.0 million for the year ended December 31, 2025, compared to $265.6 million for the year ended December 31, 2024. The increase was primarily driven by contract research and clinical trial costs for the envudeucitinib and other programs, including costs to support acceleration of clinical trial activities for the Phase 3 ONWARD clinical program, as well as increased headcount to support development efforts and severance costs, including stock-based compensation expense, related to the merger with ACELYRIN. The year ended December 31, 2024 included a clinical milestone payment of $23.0 million related to the prior acquisition of FronThera. ● General and administrative expenses were $91.9 million for the year ended December 31, 2”
Zura Bio Ltd reported full year ended December 31, 2025 results: net income Net loss was $68.7 million for the year ended December 31, 2025, EPS $(1.06) per basic and diluted share.
“Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today reported financial results for the full year ended December 31, 2025”
Biofrontera Inc. reported the fiscal year ended December 31, 2025 results: revenue $41.7 million, net income $10.5 million.
“GAAP to non-GAAP reconciliation of Adjusted EBITDA for the fourth quarters of 2025 and 2024. Full Year 2025 Financial Results Total revenues for full year 2025 increased 12% to $41.7 million compared with $37.3 million for the full year 2024. Gross profit margin for the full year 2025 was 73.7% compared to 50.1% for the prior year. Cost of goods sold related party”
Biofrontera Inc. reported the fourth quarter ended December 31, 2025 results: revenue $17.1 million, net income $5.6 million.
“financial results for the three and twelve months ended December 31, 2025 and provided a business update. Fourth Quarter Financial Highlights ● Revenues for 4Q25 were a record $17.1 million, a 36% increase compared to $12.6 million for the same period in 2024. ● Gross margins were 82.4%, a roughly 2,400 basis point year over year increase compared to 58.0% in”
MultiSensor AI Holdings, Inc. reported the year ended December 31, 2025 results: revenue $5.6 million, net income $11.7 million.
“ended December 31, 2025 was $1.9 million, an increase of 88%, compared to $1.0 million for the year ended December 31, 2024. ● Revenue for the year ended December 31, 2025 was $5.6 million, a decrease of 25%, compared to $7.4 million for the year ended December 31, 2024. ● Net loss for the year ended December 31, 2025 was $11.7 million, a decrease of 46%, compared”
Solo Brands, Inc. reported financial results for the three and twelve months ended December 31, 2025.
“Solo Brands, Inc. Announces Fiscal 2025 Fourth Quarter and Full Year Results Strategic Transformation Positions Solo Brands as a Structurally Smaller, Profit-Focused, and Innovation-Led Organization Grapevine, Texas, March 19, 2026: Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”), a leading portfolio of lifestyle brands (Solo Stove, Chubbies, ISLE and Oru) that are redefining the outdoor and apparel industries, today announced its financial results for the three and twelve months ended December 31, 2025.”
Satellogic Inc. reported fourth quarter and fiscal year ended December 31, 2025 results: revenue $6.2 million.
“--- EX-99.1 2 ex_934140.htm EXHIBIT 99.1 ex_934140.htm Exhibit 99.1 Satellogic Reports Fourth Quarter and Full Year 2025 Financial Results 94% Increase in Q4 2025 Revenue to $6.2 Million Introduces Merlin Constellation, a Fully Funded AI-First Global Daily Remapping System at 1-Meter Resolution, Targeted for October 2026 First Launch Launched Aleph Observer and”
Snail, Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue Net revenues were $25.1 million compared to $26.2 million in the same period last year., net income Net loss was $(0.9) million compared to net income of $1.1 million in the same period last year.
“Fourth Quarter 2025 Financial Highlights Net revenues were $25.1 million compared to $26.2 million in the same period last year.”
Pelthos Therapeutics Inc. reported financial results for fourth quarter and full year ended December 31, 2025.
“Pelthos Therapeutics Inc. (the “Company”) issued a press release summarizing its financial results for the three months and year ended December 31, 2025”
Strive, Inc. reported financial results for quarter ended December 31, 2025.
“On March 19, 2026, Strive, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended December 31, 2025.”
LITHIUM AMERICAS CORP. reported financial results for the fiscal quarter and the year ended December 31, 2025.
“On March 19, 2026, Lithium Americas Corp. (the “Company”) issued a press release announcing its financial and operational results for the fiscal quarter and the year ended December 31, 2025.”
Inhibrx Biosciences, Inc. reported the fourth quarter and fiscal year 2025 results: net income Net loss was $32.8 million during the fourth quarter of 2025, or $2.11 per share, basic and diluted; Net loss was $140.1.
“Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results”
Aebi Schmidt Holding AG reported the quarter and year ended December 31, 2025 results: revenue $1,907m. Guidance initiated.
“Full Year 2025 Net Sales of $1,907m, +2% vs Full Year 2024”
Gemini Space Station, Inc. reported financial results for the three and twelve months ended December 31, 2025.
“On March 19, 2026, Gemini Space Station, Inc. (“Gemini,” the “Company,” “we,” or “us”) issued a shareholder letter (the “Shareholder Letter”) and supplemental materials (the “2025 Earnings Presentation”) announcing its financial results for the three and twelve months ended December 31, 2025.”
SOLV Energy, Inc. updated its the quarter and full year ended December 31, 2025 guidance (initiated).
“SOLV Energy, Inc. issued a press release announcing its financial results for the quarter and full year ended December 31, 2025.”
Cardinal Infrastructure Group Inc. reported the year ended December 31, 2025 results: revenue $456.0 million, net income $31.1 million. Guidance reaffirmed.
“Group Inc. (NASDAQ: CDNL) (“Cardinal” or the “Company”), today announced full year 2025 financial results and affirms guidance for 2026. Full Year 2025 Highlights*: • Revenue of $456.0 million; up 45% in total or 33% organically year-over-year • Net income of $31.1 million; up 10% from full year 2024 • Adjusted earnings before interest, income taxes, depreciation and”
York Space Systems Inc. reported financial results for the fiscal quarter and year ended December 31, 2025.
“On March 19, 2026, York Space Systems Inc., a Delaware corporation (the “Company”), issued a press release announcing the Company’s financial results for the fiscal quarter and year ended December 31, 2025.”
SUNation Energy, Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue $27.2 million (Q4 2025) and $71.9 million (FY 2025), net income $2.6 million (Q4 2025).
“SUNation Energy Reports Fourth Quarter and Full Year 2025 Financial Results”
MOVADO GROUP INC reported fourth quarter and fiscal year 2026 results for the periods ended January 31, 2026 results: revenue Net sales of $671.3 million, EPS Fiscal 2026 EPS of $1.17 and Fiscal 2026 Adjusted EPS of $1.34.
“EXHIBIT 99.1 EXHIBIT 99.1 CONTACT: ICR, Inc. Allison Malkin 203-682-8225 MOVADO GROUP, INC. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS ~ Fiscal 2026 Net Sales of $671.3 million ~ ~ Fiscal 2026 Operating Income of $29.8 million and Adjusted Operating Income of $34.8 million ~ ~ Fiscal 2026 EPS of $1.17 and Fiscal 2026 Adjusted EPS of $1.34 ~ ~ Fourth”
LANDS' END, INC. reported fiscal 2025 results: revenue $1.34 billion.
“For fiscal 2025, Net revenue was $1.34 billion, a decrease of $27.8 million or 2.0% from $1.36 billion in fiscal 2024.”
LANDS' END, INC. reported fourth quarter and fiscal year ended January 30, 2026 results: revenue $462.4 million, net income $12.3 million, EPS $0.40 earnings per diluted share.
“and business-to-business channels, as well as the estimated retail value of the merchandise sold through third party distribution channels. • Net revenue was $462.4 million for the fourth quarter of fiscal 2025, an increase of $20.7 million or 4.7% from $441.7 million during the fourth quarter of fiscal 2024. • U.S. Digital Segment Net revenue was”
DESTINATION XL GROUP, INC. reported financial results for fourth quarter and fiscal year 2025, ending January 31, 2026.
“On March 19, 2026, Destination XL Group, Inc. (the “Company”) issued a press release announcing the Company’s operating results for the fourth quarter and fiscal year 2025.”
SIGNET JEWELERS LTD reported full year Fiscal 2026 (52 weeks ended January 31, 2026) results: revenue $6.81 billion, EPS $7.08. Guidance initiated.
“per share ("EPS") of $6.08, compared to $2.30 in Q4 of FY25. • Adjusted diluted EPS (3) of $6.25, compared to $6.62 in Q4 of FY25. Full Year Fiscal 2026 Highlights: • Sales of $6.81 billion on a SSS (1) increase of 1.3% to FY25. • AUR (2) was up approximately 7% to FY25, with growth in both Bridal and Fashion. • Operating income of $393.1 million, up from $110.7”
SIGNET JEWELERS LTD reported fourth quarter ended January 31, 2026 results: revenue $2.35 billion, EPS $6.08. Guidance reaffirmed.
“dynamics, and the transition of James Allen within our portfolio," said Joan Hilson, Chief Operating and Financial Officer. Fourth Quarter Fiscal 2026 Highlights: • Sales of $2.35 billion on a same store sales ("SSS") (1) decrease of 0.7% to Q4 of FY25. • Merchandise average unit retail ("AUR") (2) was up approximately 5% to Q4 of FY25, with growth in both Bridal”
ACCESS Newswire Inc. reported full year 2025 results: revenue $22.6M, net income $1.6M, EPS $0.40 per diluted share.
“Full year 2025 Highlights: · Revenue - Total revenue was $22.6M for the full year of 2025, a 2% decrease from $23.1M during the full year of 2024. The decrease is primarily related to a decrease in revenue from our PRO plan products and webcasting and events business, partially offset by an increase in revenue from our core press release business driven by increases in subscriptions. · Gross Margin - Gross margin for the full year of 2025 was $17.3M, or 77% of revenue, compared to $17.4M, or 76% of revenue, during the full year of 2024. As noted for the quarter, gross margin was impacted by lower employee costs due to optimization of our operational teams, partially offset by increased distribution costs as we continue to invest in our distribution partners. · Operating Loss - Operating loss was $1.9M, for 2025, as compared to $16.3M during 2024. The decrease in the operating loss is primarily due to the previously noted impairment charge of $14.15M recorded during 2024. · Loss from co”
ACCESS Newswire Inc. reported Q4 2025 results: revenue $5.8M, net income $0.5M, EPS $0.13 per diluted share.
“Fourth Quarter 2025 Highlights: · Revenue - Total revenue for Q4 2025 was $5.8M, consistent with Q4 2024 and an increase of 1% compared to $5.7M in Q3 2025. The increase in revenue compared to the prior quarter is primarily due to an increase in average revenue per release due to the mix of releases disseminated as well as an increase in revenue from our webcasting business. · Gross Margin - Gross margin for Q4 2025 was $4.5M, or 77% of revenue, compared to $4.4M, or 75% of revenue, in Q4 2024 and $4.3M, also 75% of revenue in Q3 2025. The increase in gross margin is primarily due to lower employee costs due to optimization of our operational teams. · Operating Loss - Operating loss was $0.8M for Q4 2025, as compared to $14.3M during Q4 2024. The primary reason for the decrease in operating loss was due to an impairment charge recorded in Q4 2024 related to the Newswire tradename of $14.15M. Absent the impairment charge, operating expenses increased $0.4M, or 10%. This increase is prim”
SCHOLASTIC CORP reported the Company’s fiscal third quarter ended February 28, 2026 results: revenue $329.1 million, EPS $2.55. Guidance reaffirmed.
“tables attached (1) Operating income and Adjusted EBITDA include a $3.0 and $6.7 impact related to the sale-leaseback transactions, respectively. Revenues decreased 2% to $329.1 million, primarily reflecting lower revenues in the Children’s Book Publishing and Distribution and International segment due to the timing of publishing releases compared to the prior”
DARDEN RESTAURANTS INC updated its third quarter ended February 22, 2026 guidance (reaffirmed).
“Darden Restaurants Reports Fiscal 2026 Third Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2026 Financial Outlook”
TEJON RANCH CO reported the fourth quarter and year-ended December 31, 2025 results: revenue $23.3 million, net income $1.6 million ($0.06/share basic and diluted), EPS $0.06/share basic and diluted.
“compared to $4.5 million ($0.17/share) in fourth quarter of 2024. • Revenues and other income, including equity in earnings from unconsolidated joint ventures, increased 8% to $23.3 million, compared to $21.6 million. • Farming segment revenues increased 26% to $12.2 million, compared to $9.7 million. • Adjusted EBITDA, a non-GAAP measure, increased 9% to $11.4”
Protalix BioTherapeutics, Inc. reported financial results for the fiscal year ended December 31, 2025.
“On March 18, 2026, Protalix BioTherapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year ended December 31, 2025 and provided a business and clinical update.”
NATURAL GAS SERVICES GROUP INC reported financial results for three months and year ended December 31, 2025.
“On March 17 2026, Natural Gas Services Group, Inc. (the “Company”) hosted an earnings call to announce the Company’s financial results for the three months and year ended December 31, 2025, and provide certain other financial and business information, along with forward guidance.”
Usio, Inc. updated its fourth quarter and year ended December 31, 2025 guidance (reaffirmed).
“On March 18, 2026, Usio, Inc. issued a press release announcing financial results for its quarter and year ended December 31, 2025.”
ACTELIS NETWORKS INC reported the full year ended December 31, 2025 results: revenue $3.7 million.
“Revenues: Our revenues for the year ended December 31, 2025 amounted to $3.7 million, compared to $7.8 million for the year ended December 31, 2024.”
FIVE BELOW, INC reported fiscal 2026 full year results: revenue $5.20 billion to $5.30 billion, net income $429 million to $457 million, EPS $7.69 to $8.20.
“For the full year of Fiscal 2026: • Net sales are expected to be in the range of $5.20 billion to $5.30 billion based on opening approximately 150 net new stores and assumes an approximate 3% to 5% increase in comparable sales. • Net income is expected to be in the range of $429 million to $457 million. Adjusted net income (4) is expected to be in the range of $431 million to $459 million. • Diluted income per common share is expected to be in the range of $7.69 to $8.20 on approximately 55.7 million diluted weighted average shares outstanding. Adjusted diluted income per common share (4) is expected to be in the range of $7.74 to $8.25.”
FIVE BELOW, INC reported fiscal 2026 first quarter results: revenue $1.18 billion to $1.20 billion, net income $86 million to $93 million, EPS $1.55 to $1.67.
“For the first quarter of Fiscal 2026: • Net sales are expected to be in the range of $1.18 billion to $1.20 billion based on opening approximately 45 net new stores and assumes an approximate 14% to 16% increase in comparable sales. • Net income is expected to be in the range of $86 million to $93 million. Adjusted net income (3) is expected to be in the range of $88 million to $94 million. • Diluted income per common share is expected to be in the range of $1.55 to $1.67 on approximately 55.6 million diluted weighted average shares outstanding. Adjusted diluted income per common share (3) is expected to be in the range of $1.57 to $1.69.”
FIVE BELOW, INC reported fiscal 2025 full year ended January 31, 2026 results: revenue $4.76 billion, net income $358.6 million, EPS $6.47.
“For the fiscal year ended January 31, 2026: • Net sales increased by 22.9% to $4.76 billion from $3.88 billion in fiscal 2024; comparable sales increased by 12.8%. • The Company opened 150 net new stores compared to 227 net new stores in fiscal 2024. • Operating income was $457.4 million compared to $323.8 million in fiscal 2024. Adjusted operating income (2) was $472.4 million compared to $356.1 million in fiscal 2024. • The effective tax rate was 25.3% compared to 25.1% in fiscal 2024. • Net income was $358.6 million compared to $253.6 million in fiscal 2024. Adjusted net income (2) was $369.9 million compared to $277.8 million in fiscal 2024. • Diluted income per common share was $6.47 compared to $4.60 in fiscal 2024. Adjusted diluted income per common share (2) was $6.67 compared to $5.04 in fiscal 2024.”
FIVE BELOW, INC reported fiscal 2025 fourth quarter ended January 31, 2026 results: revenue $1.73 billion, net income $238.2 million, EPS $4.28.
“For the fourth quarter ended January 31, 2026: • Net sales increased by 24.3% to $1.73 billion from $1.39 billion in the fourth quarter of fiscal 2024; comparable sales increased by 15.4%. • The Company opened 14 net new stores and ended the quarter with 1,921 stores in 46 states. This represents an increase in stores of 8.5% from the end of the fourth quarter of fiscal 2024. • Operating income was $310.9 million compared to $246.8 million in the fourth quarter of fiscal 2024. Adjusted operating income (1) was $312.7 million compared to $253.3 million in the fourth quarter of fiscal 2024. • The effective tax rate was 24.8% compared to 25.2% in the fourth quarter of fiscal 2024. • Net income was $238.2 million compared to $187.5 million in the fourth quarter of fiscal 2024. Adjusted net income (1) was $239.6 million compared to $192.4 million in the fourth quarter of fiscal 2024. • Diluted income per common share was $4.28 compared to $3.39 in the fourth quarter of fiscal 2024. Adjusted”
InspireMD, Inc. reported the year ended December 31, 2025 results: revenue $9.0 million, net income $48.8 million or $0.76 per basic and diluted share. Guidance initiated.
“$9.2 million or $0.19 per basic and diluted share, for the same period in 2024. Financial Results for the Year Ended December 31, 2025 For the full year 2025, total revenue was $9.0 million, representing an increase of 28%, as compared to $7.0 million during the full year 2024. U.S. revenue for the full year 2025 was $1.4 million, representing the first two quarters”
InspireMD, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $3.1 million, net income $11.8 million or $0.14 per basic and diluted share.
“of stroke, today announced financial and operating results for the fourth quarter and year ended December 31, 2025. Recent Business Highlights : ● Generated revenue of $3.1 million in the fourth quarter of 2025, up 62% year-over-year. ● Sustained strong commercial traction in the U.S. with the launch of CGuard Prime and continued growth in international”
Heartflow, Inc. reported the quarter and full year ended December 31, 2025 results: revenue $49.1 million, net income $(0.29) net loss per share.
“artery disease (CAD), today reported financial results for the fourth quarter and full year ended Dec ember 3 1 , 2025. Fourth Quarter 2025 Highlights " Total revenue of $49.1 million, a 40% increase year-over-year " Gross margin of 79.5%, non-GAAP gross margin of 79.9% " Net operating loss of $17. 8 million, non-GAAP net operating loss of $12.5 million " U.S.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.